Skip to main content
lexblog.com/lib/PQX26DVAviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "OIG: Biopharma Company’s Provision of Free Genetic Tests Does Not Warrant Sanctions Under AKS",
    "url": "https://www.lexblog.com/2022/05/17/oig-biopharma-companys-provision-of-free-genetic-tests-does-not-warrant-sanctions-under-aks/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-PQX26DVA",
        "url": "https://www.lexblog.com/lib/PQX26DVA/"
    },
    "datePublished": "2022-05-17T13:37:29-04:00",
    "dateModified": "2022-05-31T09:26:38-04:00",
    "author": {
        "@type": "Person",
        "name": "Jeffrey Ehrhardt, Jeff Kaiser"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rivkin Radler"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Rivkin Rounds",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.rivkinrounds.com/?p=3255",
    "sourceStability": "may-move"
}